Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα

• Published in: Blood Vol. 111; no. 12; pp. 5727 - 5733
• Main Authors: Pinto, Jorge P., Ribeiro, Sara, Pontes, Helena, Thowfeequ, Shifaan, Tosh, David, Carvalho, Félix, Porto, Graça
• Format: Journal Article
• Language: English
• Published: Washington, DC Elsevier Inc 15.06.2008; The Americain Society of Hematology; American Society of Hematology
• Series: Red Cells
• Subjects: Biological and medical sciences; Cell differentiation, maturation, development, hematopoiesis; Cell physiology; Fundamental and applied biological sciences. Psychology; Molecular and cellular biology; RED CELLS; Erythropoiesis; Human; Erythropoietin; Digestive system; Liver; Rodentia; Red blood cell; Iron; C/EBP transcription factor; Signal transduction; Vertebrata; Mammalia; Hepatocyte; Mouse; Polypeptide; Animal; Established cell line; Hepcidin
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood-2007-08-106195

Hepcidin is the principal iron regulatory hormone, controlling the systemic absorption and remobilization of iron from intracellular stores. Recent in vivo studies have shown that hepcidin is down-regulated by erythropoiesis, anemia, and hypoxia, which meets the need of iron input for erythrocyte production. Erythropoietin (EPO) is the primary signal that triggers erythropoiesis in anemic and hypoxic conditions. Therefore, a direct involvement of EPO in hepcidin regulation can be hypothesized. We report here the regulation of hepcidin expression by EPO, in a dose-dependent manner, in freshly isolated mouse hepatocytes and in the HepG2 human hepatocyte cell model. The effect is mediated through EPOR signaling, since hepcidin mRNA levels are restored by pretreatment with an EPOR-blocking antibody. The transcription factor C/EBPα showed a pattern of expression similar to hepcidin, at the mRNA and protein levels, following EPO and anti-EPOR treatments. Chromatin immunoprecipitation experiments showed a significant decrease of C/EBPα binding to the hepcidin promoter after EPO supplementation, suggesting the involvement of this transcription factor in the transcriptional response of hepcidin to EPO.